Chemours Company (The) (NYSE:CC) : 5 analysts are covering Chemours Company (The) (NYSE:CC) and their average rating on the stock is 3, which is read as a Hold. 1 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. However, 1 analysts consider that the stock has more downward risks ahead, hence, they suggest a Strong Sell on the stock. A total of 3 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
Chemours Company (The) (NYSE:CC) : The highest level Chemours Company (The) (NYSE:CC) is projected to reach is $15 for the short term and the lowest estimate is at $9. The consolidated price target from 4 rating analysts who initiate coverage on the stock is $11.75 and the possibility the share price can swing is $2.75.
Company shares have received an average consensus rating of Hold for the current week Also, Major Brokerage house, Citigroup maintains its ratings on Chemours Company (The) (NYSE:CC). In the latest research report, Citigroup raises the target price from $5 per share to $8 per share. According to the latest information available, the shares are now rated Neutral by the analysts at the agency. The rating by the firm was issued on April 18, 2016.
Chemours Company (The) (NYSE:CC): stock turned positive on Tuesday. Though the stock opened at $8.74, the bulls momentum made the stock top out at $8.77 level for the day. The stock recorded a low of $8.19 and closed the trading day at $8.45, in the green by 0.12%. The total traded volume for the day was 2,575,727. The stock had closed at $8.44 in the previous days trading.
In an insider trading activity, Newman Mark, CFO of Chemours Co, executed a transaction worth $27,160 on May 13, 2016. A total of 2,800 shares were purchased at an average price of $9.7. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, general industrial, and mining and oil refining. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands, including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands, including Suva, ISCEON, Freon, Opteon, Teflon, Tefzel, Viton, Krytox, Formacel, Dymel, FM 200, Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands, including Virkon and Oxone. The Companys products include titanium dioxide, refrigerants, industrial fluoropolymer resins, sodium cyanide, sulfuric acid and aniline.